• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NasdaqCM
    0.39 Down 0.03(7.14%) Apr 29, 3:58PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 421   715   296   512  
    Cost of Revenue -   -   -   -  
    Gross Profit 421   715   296   512  
    Operating Expenses
    Research Development2,556  2,904  2,580  4,342  
    Selling General and Administrative1,726  1,205  1,333  1,468  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (3,861) (3,394) (3,617) (5,298)
    Income from Continuing Operations
    Total Other Income/Expenses Net(11)207  (135)(377)
    Earnings Before Interest And Taxes(3,872)(3,187)(3,752)(5,675)
    Interest Expense -   -   -   -  
    Income Before Tax(3,872)(3,187)(3,752)(5,675)
    Income Tax Expense(498)(478)(405)(763)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,374)(2,709)(3,347)(4,912)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,374) (2,709) (3,347) (4,912)
    Preferred Stock And Other Adjustments(51)(50)(50)(50)
    Net Income Applicable To Common Shares (3,425) (2,759) (3,397) (4,962)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.